Abbott India Limited (BOM:500488)
India · Delayed Price · Currency is INR 26,712
-140 (-0.52%)
At close: Jul 7, 2026
Abbott India Market Cap
Abbott India has a market cap or net worth of 567.61 billion as of July 7, 2026. Its market cap has decreased by -15.62% in one year.
Market Cap
567.61B
Enterprise Value
545.47B
Revenue
69.29B
Ranking
n/a
PE Ratio
36.57
Stock Price
26,712.05
Market Cap Chart
Since February 21, 2002, Abbott India's market cap has increased from 4.77B to 567.61B, an increase of 11,801.43%. That is a compound annual growth rate of 21.65%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 7, 2026 | 567.61B | -8.11% |
| Dec 31, 2025 | 617.71B | -2.27% |
| Dec 31, 2024 | 632.08B | 30.17% |
| Dec 29, 2023 | 485.60B | 6.63% |
| Dec 30, 2022 | 455.40B | 10.06% |
| Dec 31, 2021 | 413.77B | 23.55% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Torrent Pharmaceuticals | 1.61T |
| Dr. Reddy's Laboratories | 1.14T |
| Lupin | 1.13T |
| GlaxoSmithKline Pharmaceuticals | 405.35B |
| J. B. Chemicals & Pharmaceuticals | 379.44B |
| Rubicon Research | 215.33B |
| AstraZeneca Pharma India | 207.45B |
| Granules India | 206.45B |